FASIHA KANWAL to Cost of Illness
This is a "connection" page, showing publications FASIHA KANWAL has written about Cost of Illness.
Connection Strength
1.974
-
Increasing Health Care Burden of Chronic Liver Disease Compared With Other Chronic Diseases, 2004-2013. Gastroenterology. 2018 09; 155(3):719-729.e4.
Score: 0.479
-
Global epidemiology and burden of HCV infection and HCV-related disease. Nat Rev Gastroenterol Hepatol. 2017 02; 14(2):122-132.
Score: 0.433
-
Hepatocellular cancer care: cost is important but only one factor of disease burden. J Hepatol. 2009 Jan; 50(1):10-2.
Score: 0.247
-
Evolving burden of metabolic dysfunction-associated steatotic liver disease and its complications in a US nationwide healthcare system. Hepatol Commun. 2026 Jan 01; 10(1).
Score: 0.203
-
Actionable Solutions to Achieve Health Equity in Chronic Liver Disease. Clin Gastroenterol Hepatol. 2023 07; 21(8):1992-2000.
Score: 0.168
-
Impact of COVID-19 Pandemic on Liver Transplantation and Alcohol-Associated Liver Disease in the USA. Hepatology. 2021 12; 74(6):3316-3329.
Score: 0.151
-
Assessment of the Feasibility and Cost of Hepatitis C Elimination in Pakistan. JAMA Netw Open. 2019 05 03; 2(5):e193613.
Score: 0.128
-
Hepatitis C Disease Burden in the United States in the era of oral direct-acting antivirals. Hepatology. 2016 11; 64(5):1442-1450.
Score: 0.105
-
Racial and ethnic disparities in non-alcoholic fatty liver disease in the USA. Lancet Gastroenterol Hepatol. 2021 06; 6(6):422-424.
Score: 0.037
-
The impact of hepatitis C burden: an evidence-based approach. Aliment Pharmacol Ther. 2014 Mar; 39(5):518-31.
Score: 0.022